GPCRs are a large group of cell surface receptors that have an important role in pharmacology in present times. GPCRs or G-protein-coupled receptors have wide-ranging functions in the human body. GPCRs comprise cell surface receptors that respond to an extensive assortment of external stimuli and have a crucial purpose in cell communication. GPCRs are the target for almost 30% of drugs that are on the market as well as the drugs that are presently being developed.
Browse Full GPCRs Market Report With Complete TOC @ http://www.transparencymarketresearch.com/g-protein-coupled-receptors-market.html
The GPCRs market is anticipated to expand at an encouraging CAGR of 8.8% to reach a total value of US$3,533.4 million by 2022. The key causes for growth of the global GPCRs market are the mounting demand for a variety of GPCRs assays related to drug development and the proliferation of respiratory, cardiovascular, nervous system, and reproductive disorders all over the world.
HPS and Drug Discovery Platforms Need Drives Demand for cAMP Assay
The category segmentation for GPCRs market is based on six assay types. These are GTPγS binding assays, cAMP assays, receptor internalization assays, reporter gene assays, GTPγS binding assays, and calcium level detection assays. Increasing demand for cAMP assays used in major drug discovery platforms and high throughput screening (HTS) has led to this segment occupying the largest GPCRs market share of 32.5% in 2013. cAMP assays are also used in a variety of drug discovery platforms and range of therapeutic applications, so market growth for this segment can be attributed to demand from these related applications as well. The growth of this segment is expected to continue over the next few years. The cAMP segment was followed by the segment for calcium level detection assays with the second highest market share of the GPCRs market in 2013.
Precision as well as linearity, large signal to background ratio, and wide...